Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo

Immunity

Volumn 21, Issue 2, 2004, Pages 155-165

  Shen, Lianjun ^a   Sigal, Luis J ^b   Boes, Marianne ^c   Rock, Kenneth L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLSERYLASPARAGINYLGLUTAMYLASPARAGINYLMETHIONYLGLUTAMYLTHREONYL METHIONINE; AMINO ACID DERIVATIVE; ANTIGEN; CATHEPSIN S; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; EPITOPE; LACTACYSTIN BETA LACTONE; LEUPEPTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; PROTEASOME INHIBITOR; RECOMBINANT PROTEIN; SERYLSERYLLEUCYLGLUTAMYLASPARAGINYLPHENYLALANYLARGINYLALANYLTYROSYLVALINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; DENDRITIC CELL; HYDROLYSIS; IMMUNE SYSTEM; INFLUENZA VIRUS; MOUSE; NONHUMAN; PARENCHYMA; PHAGOSOME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; VIRUS INFECTION; VIRUS MUTATION;

ANIMALS; ANTIGEN PRESENTATION; CATHEPSINS; DNA VIRUS INFECTIONS; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOGLOBULIN CONSTANT REGIONS; MICE; VACCINIA VIRUS;

EID: 4143146210     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2004.07.004     Document Type: Article

References (58)

1. Ackerman A.L., Kyritsis C., Tampe R., Cresswell P. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc. Natl. Acad. Sci. USA. 100:2003;12889-12894
2. Barber D.L., Wherry E.J., Ahmed R. Cutting edge. rapid in vivo killing by memory CD8 T cells J. Immunol. 171:2003;27-31
3. Belz G.T., Wodarz D., Diaz G., Nowak M.A., Doherty P.C. Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J. Virol. 76:2002;12388-12393
4. Cervi L., MacDonald A.S., Kane C., Dzierszinski F., Pearce E.J. Cutting edge. dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific th2 responses J. Immunol. 172:2004;2016-2020
5. Chapman H.A., Riese R.J., Shi G.P. Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59:1997;63-88
6. Chefalo P.J., Grandea A.G. III, Van Kaer L., Harding C.V. Tapasin-/- and TAP1-/- macrophages are deficient in vacuolar alternate class I MHC (MHC-I) processing due to decreased MHC-I stability at phagolysosomal pH. J. Immunol. 170:2003;5825-5833
7. Craiu A., Gaczynska M., Akopian T., Gramm C.F., Fenteany G., Goldberg A.L., Rock K.L. Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J. Biol. Chem. 272:1997;13437-13445
8. den Haan J.M., Lehar S.M., Bevan M.J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192:2000;1685-1696
9. Desjardins M., Huber L.A., Parton R.G., Griffiths G. Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus. J. Cell Biol. 124:1994;677-688
10. Deussing J., Roth W., Saftig P., Peters C., Ploegh H.L., Villadangos J.A. Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc. Natl. Acad. Sci. USA. 95:1998;4516-4521
11. Fonteneau J.F., Kavanagh D.G., Lirvall M., Sanders C., Cover T.L., Bhardwaj N., Larsson M. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. Blood. 102:2003;4448-4455
12. Freigang S., Egger D., Bienz K., Hengartner H., Zinkernagel R.M. Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming. Proc. Natl. Acad. Sci. USA. 100:2003;13477-13482
13. Guermonprez P., Saveanu L., Kleijmeer M., Davoust J., Van Endert P., Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature. 425:2003;397-402
14. Heath W.R., Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19:2001;47-64
15. Houde M., Bertholet S., Gagnon E., Brunet S., Goyette G., Laplante A., Princiotta M.F., Thibault P., Sacks D., Desjardins M. Phagosomes are competent organelles for antigen cross-presentation. Nature. 425:2003;402-406
16. Huang A.Y., Golumbek P., Ahmadzadeh M., Jaffee E., Pardoll D., Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science. 264:1994;961-965
17. Huang A.Y., Bruce A.T., Pardoll D.M., Levitsky H.I. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity. 4:1996;349-355
18. + T cells by exogenous cell-associated antigens. Immunity. 17:2002;211-220
19. Kleindienst P., Brocker T. Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo. J. Immunol. 170:2003;2817-2823
20. Kovacsovics-Bankowski M., Clark K., Benacerraf B., Rock K.L. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA. 90:1993;4942-4946
21. Kovacsovics-Bankowski M., Rock K.L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science. 267:1995;243-246
22. Kurts C., Heath W.R., Carbone F.R., Allison J., Miller J.F., Kosaka H. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184:1996;923-930
23. Lennon-Dumenil A.M., Bakker A.H., Maehr R., Fiebiger E., Overkleeft H.S., Rosemblatt M., Ploegh H.L., Lagaudriere-Gesbert C. Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J. Exp. Med. 196:2002;529-540
24. Li M., Davey G.M., Sutherland R.M., Kurts C., Lew A.M., Hirst C., Carbone F.R., Heath W.R. Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J. Immunol. 166:2001;6099-6103
25. Liu K., Iyoda T., Saternus M., Kimura Y., Inaba K., Steinman R.M. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196:2002;1091-1097
26. Mintern J.D., Davey G.M., Belz G.T., Carbone F.R., Heath W.R. Cutting edge. precursor frequency affects the helper dependence of cytotoxic T cells J. Immunol. 168:2002;977-980
27. Nakagawa T.Y., Rudensky A.Y. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation. Immunol. Rev. 172:1999;121-129
28. Nakagawa T., Roth W., Wong P., Nelson A., Farr A., Deussing J., Villadangos J.A., Ploegh H., Peters C., Rudensky A.Y. Cathepsin L. critical role in Ii degradation and CD4 T cell selection in the thymus Science. 280:1998;450-453
29. Nakagawa T.Y., Brissette W.H., Lira P.D., Griffiths R.J., Petrushova N., Stock J., McNeish J.D., Eastman S.E., Howard E.D., Clarke S.R., et al. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity. 10:1999;207-217
30. Norbury C.C., Hewlett L.J., Prescott A.R., Shastri N., Watts C. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity. 3:1995;783-791
31. Norbury C.C., Princiotta M.F., Bacik I., Brutkiewicz R.R., Wood P., Elliott T., Bennink J.R., Yewdell J.W. Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo. J. Immunol. 166:2001;4355-4362
32. Oh Y.K., Swanson J.A. Different fates of phagocytosed particles after delivery into macrophage lysosomes. J. Cell Biol. 132:1996;585-593
33. Pfeifer J.D., Wick M.J., Roberts R.L., Findlay K., Normark S.J., Harding C.V. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature. 361:1993;359-362
34. Reimann J., Schirmbeck R. Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation. Immunol. Rev. 172:1999;131-152
35. Rock K.L. A new foreign policy. MHC class I molecules monitor the outside world Immunol. Today. 17:1996;131-137
36. Rock K.L., Clark K. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway. J. Immunol. 156:1996;3721-3726
37. Rock K.L., Goldberg A.L. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17:1999;739-779
38. Rock K.L., Gamble S., Rothstein L. Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science. 249:1990;918-921. a
39. Rock K.L., Rothstein L., Gamble S. Generation of class I MHC-restricted T-T hybridomas. J. Immunol. 145:1990;804-811. b
40. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., Goldberg A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78:1994;761-771
41. Rodriguez A., Regnault A., Kleijmeer M., Ricciardi-Castagnoli P., Amigorena S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell Biol. 1:1999;362-368
42. Ruedl C., Storni T., Lechner F., Bachi T., Bachmann M.F. Cross-presentation of virus-like particles by skin-derived CD8(-) dendritic cells. a dispensable role for TAP Eur. J. Immunol. 32:2002;818-825
43. Serna A., Ramirez M.C., Soukhanova A., Sigal L.J. Efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells. J. Immunol. 171:2003;5668-5672
44. Shen L., Rock K.L. Cellular protein is the source of cross-priming antigen in vivo. Proc. Natl. Acad. Sci. USA. 101:2004;3035-3040
45. Shen Z., Reznikoff G., Dranoff G., Rock K.L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158:1997;2723-2730
46. Shen X., Wong S.B., Buck C.B., Zhang J., Siliciano R.F. Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes. J. Immunol. 169:2002;4222-4229
47. Shi G.P., Munger J.S., Meara J.P., Rich D.H., Chapman H.A. Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J. Biol. Chem. 267:1992;7258-7262
48. Shi G.P., Villadangos J.A., Dranoff G., Small C., Gu L., Haley K.J., Riese R., Ploegh H.L., Chapman H.A. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity. 10:1999;197-206
49. Shi G.P., Bryant R.A., Riese R., Verhelst S., Driessen C., Li Z., Bromme D., Ploegh H.L., Chapman H.A. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. 191:2000;1177-1186
50. Sigal L.J., Rock K.L. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation. J. Exp. Med. 192:2000;1143-1150
51. Sigal L.J., Crotty S., Andino R., Rock K.L. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature. 398:1999;77-80
52. Song R., Harding C.V. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J. Immunol. 156:1996;4182-4190
53. Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells. chaperoning of the innate and adaptive immune responses Annu. Rev. Immunol. 20:2002;395-425
54. Sugita M., Brenner M.B. Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments. J. Biol. Chem. 270:1995;1443-1448
55. Vigna J.L., Smith K.D., Lutz C.T. Invariant chain association with MHC class I. preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove J. Immunol. 157:1996;4503-4510
56. Villadangos J.A., Bryant R.A., Deussing J., Driessen C., Lennon-Dumenil A.M., Riese R.J., Roth W., Saftig P., Shi G.P., Chapman H.A., et al. Proteases involved in MHC class II antigen presentation. Immunol. Rev. 172:1999;109-120
57. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15:1997;821-850
58. Wick M.J., Pfeifer J.D. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources. protein context influences the degree of TAP-independent presentation Eur. J. Immunol. 26:1996;2790-2799